Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT05618158
Other study ID # 0341
Secondary ID 1R01CA268037-01A
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date April 20, 2024
Est. completion date February 28, 2027

Study information

Verified date March 2024
Source Klein Buendel, Inc.
Contact David Buller, PhD
Phone 3035654321
Email dbuller@kleinbuendel.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Young adults aged 18-26 engage in a number of behaviors that increase their risk of developing cancer later in life including sedentary lifestyles, unhealthy eating, nicotine produce us, heavy drinking of alcohol, increased UV exposure, and incomplete uptake of HPV vaccination. A multi-risk factor campaign will be developed to reduce these cancer risk behaviors and delivered to young adults over social media, a popular channel that can reach nearly all young adults. The campaign will be evaluated for effectiveness in a rigorous randomized trial with measures of moderate to vigorous physical activity, healthy eating patterns, nicotine product use, alcohol intake, sunburn prevalence, and HPV vaccination uptake.


Description:

Several risk factors are prevalent during early adulthood that can lead to cancer later in life. Emerging adults (EAs) aged 18-26 residing in rural areas of the United States engage in many cancer risk behaviors, especially sedentary lifestyles, poor eating patterns, nicotine product use, excess alcohol intake, infrequent sun protection, and inadequate uptake of the HPV vaccine. This application responds to RFA-CA-20-051, "Social and Behavioral Intervention Research to Address Modifiable Risk Factors for Cancer in Rural Populations." The goal is to improve cancer risk behavioral factors among diverse EAs aged 18-26 living in rural counties in the Four Corners states, a unique, underserved region, using a social media campaign designed with community advisors. EAs, including in rural communities, are heavy consumers of online content, especially over social media, and social media provide responsive, engaging, and low-cost platforms for distributing cancer prevention information with high dissemination potential. But, social media also circulate inaccurate, misleading, and harmful information. The specific aims of this research are to: 1) Develop a social media intervention for diverse EAs in rural communities via a community-engaged process that combines expert advice, user-generated content, and online instruction to communicate about behavioral cancer risks, cancer misinformation, counter marketing, digital and media literacy, and family communication; 2) evaluate the effect of a theory-based social media intervention on moderate to vigorous physical activity (MVPA), healthy eating patterns, nicotine product use, alcohol intake, sunburn prevalence, and HPV vaccination with the diverse population of EAs aged 18-26 in rural counties in AZ, CO, NM, and UT (Four Corners states) recruited from Qualtrics' survey panel and enrolled in a pragmatic randomized trial using a stepped-wedge design in which individual EAs will be randomized to 1 of 4 cohorts and receive the social media feed for varying durations in separate Facebook private groups; 3) test if improvements in EAs' cancer risk knowledge and beliefs, digital and media literacy skills, accurate cancer prevention information, and family communication mediate impact of the social media campaign; and 4) explore whether the impact of the social media campaign differs according to: a) level of EAs' engagement with campaign, b) cancer risk factors, and c) biological sex of the participants (as required by NIH). The research is innovative because it tests a theory-based, multi-risk factor approach to cancer prevention with diverse EAs in rural counties, an under-studied population, in a very popular new media. Social media may reach EAs more than interventions through other community channels (e.g., clinics, schools, and workplaces) and for lower cost in the geographically-dispersed, underserved rural communities in the Mountain West. The overall impact is extremely high because it will aid rural EAs in making informed decisions that reduce cancer risk factors and prevent cancer later in life and help EAs critically evaluate and resist misinformation and marketing that promote cancer risk behaviors.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 1000
Est. completion date February 28, 2027
Est. primary completion date November 30, 2026
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 26 Years
Eligibility Inclusion Criteria: - Aged 18-26 years old - Resides in a county coded as RUCC 4-9 in Arizona, Colorado, New Mexico, or Utah - Able to speak and read English - Has regular social media engagement - Accepts screening call from study staff - Consents to participate Exclusion Criteria: - Participated in community engagement activities - Cannot speak and read English - Has low or no social media engagement - Does not accept a screening call from study staff - Does not consent to participate - Does not give permission for engagement data to be extracted from Facebook private group - If biologically female, currently pregnant

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
4 Corners Rural Health Cancer Prevention
Participants, aged 18-26, will join a private Facebook group to participate in the intervention. The group is not viewable to the public, including other Facebook users. Content that focuses on cancer prevention behaviors will be posted twice per day for up to 12 months. Each group will be hosted by a moderator who is responsible for managing the intervention goals and participants' engagement.

Locations

Country Name City State
United States University of New Mexico Albuquerque New Mexico
United States University of Colorado Denver Aurora Colorado
United States Colorado State University Fort Collins Colorado
United States University of Utah Salt Lake City Utah
United States University of Arizona Tucson Arizona

Sponsors (7)

Lead Sponsor Collaborator
Klein Buendel, Inc. Colorado State University, National Cancer Institute (NCI), University of Arizona, University of Colorado, Denver, University of New Mexico, University of Utah

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Physical Activity Participants will self-report minutes per week of moderate to vigorous physical activity. Baseline
Primary Physical Activity Participants will self-report minutes per week of moderate to vigorous physical activity. 3 months
Primary Physical Activity Participants will self-report minutes per week of moderate to vigorous physical activity. 12 months
Primary Physical Activity Participants will self-report minutes per week of moderate to vigorous physical activity. 24 months
Primary Diet Participants will self-report intake per day of fruits, vegetables, whole grains/fiber, added sugars (from sugar-sweetened beverages), and red/processed meats. Baseline
Primary Diet Participants will self-report intake per day of fruits, vegetables, whole grains/fiber, added sugars (from sugar-sweetened beverages), and red/processed meats. 3 months
Primary Diet Participants will self-report intake per day of fruits, vegetables, whole grains/fiber, added sugars (from sugar-sweetened beverages), and red/processed meats. 12 months
Primary Diet Participants will self-report intake per day of fruits, vegetables, whole grains/fiber, added sugars (from sugar-sweetened beverages), and red/processed meats. 24 months
Primary Nicotine Product Use Participants will self-report tobacco/nicotine use in the past 30 days (every day, some days, not at all). Baseline
Primary Nicotine Product Use Participants will self-report tobacco/nicotine use in the past 30 days (every day, some days, not at all). 3 months
Primary Nicotine Product Use Participants will self-report tobacco/nicotine use in the past 30 days (every day, some days, not at all). 12 months
Primary Nicotine Product Use Participants will self-report tobacco/nicotine use in the past 30 days (every day, some days, not at all). 24 months
Primary Alcohol Intake Participants self-report consumption of number of alcoholic drinks in the past 30 days. Baseline
Primary Alcohol Intake Participants self-report consumption of number of alcoholic drinks in the past 30 days. 3 months
Primary Alcohol Intake Participants self-report consumption of number of alcoholic drinks in the past 30 days. 12 months
Primary Alcohol Intake Participants self-report consumption of number of alcoholic drinks in the past 30 days. 24 months
Primary Uv Exposure Participants will self-report number of sunburns. Baseline
Primary Uv Exposure Participants will self-report number of sunburns. 3 months
Primary Uv Exposure Participants will self-report number of sunburns. 12 months
Primary Uv Exposure Participants will self-report number of sunburns. 24 months
Primary HPV Vaccination Participants will self-report whether or not they have received one or more doses of the HPV vaccine. Baseline
Primary HPV Vaccination Participants will self-report whether or not they have received one or more doses of the HPV vaccine. 3 months
Primary HPV Vaccination Participants will self-report whether or not they have received one or more doses of the HPV vaccine. 12 months
Primary HPV Vaccination Participants will self-report whether or not they have received one or more doses of the HPV vaccine. 24 months
Secondary Physical Activity Participants will self-report number of minutes per week engaging in physical activity to determine if they meet the 150 minutes per week recommendation. Baseline
Secondary Physical Activity Participants will self-report number of minutes per week engaging in physical activity to determine if they meet the 150 minutes per week recommendation. 3 months
Secondary Physical Activity Participants will self-report number of minutes per week engaging in physical activity to determine if they meet the 150 minutes per week recommendation. 12 months
Secondary Physical Activity Participants will self-report number of minutes per week engaging in physical activity to determine if they meet the 150 minutes per week recommendation. 24 months
Secondary Diet Participants will self-report frequency of eating meals away from home/fast food. Baseline
Secondary Diet Participants will self-report frequency of eating meals away from home/fast food. 3 months
Secondary Diet Participants will self-report frequency of eating meals away from home/fast food. 12 months
Secondary Diet Participants will self-report frequency of eating meals away from home/fast food. 24 months
Secondary Nicotine Product Use Participants will self-report tobacco/nicotine use in the past 7 days (every day, some days, not at all). Baseline
Secondary Nicotine Product Use Participants will self-report tobacco/nicotine use in the past 7 days (every day, some days, not at all). 3 months
Secondary Nicotine Product Use Participants will self-report tobacco/nicotine use in the past 7 days (every day, some days, not at all). 12 months
Secondary Nicotine Product Use Participants will self-report tobacco/nicotine use in the past 7 days (every day, some days, not at all). 24 months
Secondary Nicotine Product Use Participants will self-report readiness to quit using a 10 point rating scale (1=no thought of quitting; 10=taking action to quit). Baseline
Secondary Nicotine Product Use Participants will self-report readiness to quit using a 10 point rating scale (1=no thought of quitting; 10=taking action to quit). 3 months
Secondary Nicotine Product Use Participants will self-report readiness to quit using a 10 point rating scale (1=no thought of quitting; 10=taking action to quit). 12 months
Secondary Nicotine Product Use Participants will self-report readiness to quit using a 10 point rating scale (1=no thought of quitting; 10=taking action to quit). 24 months
Secondary Alcohol Intake Participants will self-report number of times binge drinking in the past 30 days. Baseline
Secondary Alcohol Intake Participants will self-report number of times binge drinking in the past 30 days. 3 months
Secondary Alcohol Intake Participants will self-report number of times binge drinking in the past 30 days. 12 months
Secondary Alcohol Intake Participants will self-report number of times binge drinking in the past 30 days. 24 months
Secondary UV Exposure Participants will self-report sun protection behaviors with percent of sun exposure hours using sun protection. Baseline
Secondary UV Exposure Participants will self-report sun protection behaviors with percent of sun exposure hours using sun protection. 3 months
Secondary UV Exposure Participants will self-report sun protection behaviors with percent of sun exposure hours using sun protection. 12 months
Secondary UV Exposure Participants will self-report sun protection behaviors with percent of sun exposure hours using sun protection. 24 months
Secondary HPV Vaccination Participants will self-report if they have completed the series of HPV vaccination by receiving 3 doses of the vaccine. Baseline
Secondary HPV Vaccination Participants will self-report if they have completed the series of HPV vaccination by receiving 3 doses of the vaccine. 3 months
Secondary HPV Vaccination Participants will self-report if they have completed the series of HPV vaccination by receiving 3 doses of the vaccine. 12 months
Secondary HPV Vaccination Participants will self-report if they have completed the series of HPV vaccination by receiving 3 doses of the vaccine. 24 months
See also
  Status Clinical Trial Phase
Recruiting NCT05346796 - Survivorship Plan HEalth REcord (SPHERE) Implementation Trial N/A
Recruiting NCT05094804 - A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents Phase 1/Phase 2
Completed NCT04867850 - Effect of Behavioral Nudges on Serious Illness Conversation Documentation N/A
Enrolling by invitation NCT04086251 - Remote Electronic Patient Monitoring in Oncology Patients N/A
Completed NCT01285037 - A Study of LY2801653 in Advanced Cancer Phase 1
Completed NCT00680992 - Study of Denosumab in Subjects With Giant Cell Tumor of Bone Phase 2
Completed NCT00062842 - Study of Irinotecan on a Weekly Schedule in Children Phase 1
Active, not recruiting NCT04548063 - Consent Forms in Cancer Research: Examining the Effect of Length on Readability N/A
Completed NCT04337203 - Shared Healthcare Actions and Reflections Electronic Systems in Survivorship N/A
Recruiting NCT04349293 - Ex-vivo Evaluation of the Reactivity of the Immune Infiltrate of Cancers to Treatments With Monoclonal Antibodies Targeting the Immunomodulatory Pathways N/A
Terminated NCT02866851 - Feasibility Study of Monitoring by Web-application on Cytopenia Related to Chemotherapy N/A
Active, not recruiting NCT05304988 - Development and Validation of the EFT for Adolescents With Cancer
Completed NCT00340522 - Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development
Recruiting NCT04843891 - Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis. Phase 1
Active, not recruiting NCT03844048 - An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial Phase 3
Completed NCT03109041 - Initial Feasibility Study to Treat Resectable Pancreatic Cancer With a Planar LDR Source Phase 1
Completed NCT03167372 - Pilot Comparison of N-of-1 Trials of Light Therapy N/A
Terminated NCT01441115 - ECI301 and Radiation for Advanced or Metastatic Cancer Phase 1
Recruiting NCT06206785 - Resting Energy Expenditure in Palliative Cancer Patients
Recruiting NCT05318196 - Molecular Prediction of Development, Progression or Complications of Kidney, Immune or Transplantation-related Diseases